Drug developer jazzed to receive FDA approval for leukemia treatment
August 03, 2017 at 11:46 AM EDT
Company: Vyxeos is the first new chemotherapy advance in more than 40 years for adults with two types of acute myeloid leukemia.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.